Also, integrin β4 interacts with multiple receptor tyrosine kinases, such as EGF-R, ErbB2, and Met and enhances the signaling function of RTKs, in which deregulated joint β4-RTK signaling influences tumor progression [20, 21]. Here, EGFR is linked to neoplasm.